1.Influence of Long-Term Inhaled Glucocoticoids on Soluble Intercellular Adhesion Molecule-1 of Bronchial Asthmatic Children
ding-rong, ZHANG ; rong-jun, LIN ; wen-wei, WU ; yan-shi, SHAO ; li-rong, SUN
Journal of Applied Clinical Pediatrics 2006;0(18):-
Objective To explore influence of long-term inhaled glucocoticoids(IGS) on soluble intercellular adhesion molecule-1(sICAM-1)) in children with bronchial asthma.Methods Enzyme-linked immunosorbent assay(ELISA) method was used to detect the serum sICAM-1 level in 36 healthy children and 29 children with bronchial asthma(untreated and post-treated for 3,6 and 12 months).Results 1.Serum sICAM-1 level was significantly elevated in children with asthma and significantly higher than that in normal control group(P
2.Research on composition rules of prescriptions dealing with syndrome of deficiency of both qi and blood from National Standard for Chinese Patent Drugs.
Wei-rong SHAO ; Dan SHEN ; Shi-huan TANG
China Journal of Chinese Materia Medica 2015;40(9):1817-1820
Based on the software of Traditional Chinese Medicine Inheritance Support System (TCMISS), the article made analysis on the composition rules of prescriptions dealing with syndrome of deficiency of both qi and blood from National Standard for Chinese Patent Drugs (NSCPD) enacted by Ministry of Public Health of China. First, prescriptions were collected from NSCPD. Second, used integrated data mining methods in TCMISS, including association rules, improved mutual information method, et al. to analyze the medication rules. At last, irregular menstruation, insomnia, consumptive diseases with the same syndrome of deficiency of both qi and blood, were chosen to make comparative analysis on frequency of medicines used, core drug combinations, et al. to better find the similarities and differences of medications rules when confronted with the same syndrome while different diseases. And the similar core drug combinations directly reflected the characters of clinical practices of traditional Chinese medicine, which emphasizes on the treatment based on the syndromes of differentiation, and treating different diseases with the same methods.
Blood Circulation
;
drug effects
;
Drug Combinations
;
Drug Prescriptions
;
standards
;
Drugs, Chinese Herbal
;
chemistry
;
pharmacology
;
Humans
;
Medicine, Chinese Traditional
;
Phytotherapy
;
standards
;
Qi
3.Acid and Bile Reflux in Children with Gastroesophageal Reflux Disease
ju-rong, WEI ; shao-ming, ZHOU ; hong-ying, LUO ; da-ming, BAI ; cheng-rong, LI
Journal of Applied Clinical Pediatrics 2004;0(09):-
Objective To investigate the role of acid and bile reflux in children with gastroesophageal reflux disease (GERD) and to evaluate the significance of detecting acid and bile reflux in diagnosing GERD in children.Methods Using ambulatory 24 h pH mo-(nitoring) and bilirubin monitoring technique, we simultaneously assessed the changes of intraesophageal pH and bile reflux in 23 subjects (including 11 healthy controls and 12 patients with GERD).Results The time of esophageal acid exposure (pH
4.Progress of study on anti-human cervical papilloma virus infection with Chinese and Western medicine.
Ming-Cheng LI ; Wei LIU ; Wei-Rong SHAO
Chinese Journal of Integrated Traditional and Western Medicine 2007;27(6):573-575
Human papilloma virus (HPV) infection is closely correlated with the occurrence of cervical cancer and precancerous lesion, high risk HPV can induce cervical cancer by the corresponding protein of E6 and E7 gene expression. Earlier diagnosis and earlier prevention of HPV infection are the key points in blocking cervical cancer, and combined use of Chinese herbal preparations with Western medicine is the important way for preventing HPV infection and prohibiting cervical canceration. So, to develop anti-viral chemical compound from natural drugs has become the hotspot of research today.
Drug Therapy, Combination
;
Drugs, Chinese Herbal
;
therapeutic use
;
Female
;
Humans
;
Interferons
;
therapeutic use
;
Oncogene Proteins, Viral
;
analysis
;
Papillomavirus E7 Proteins
;
analysis
;
Papillomavirus Infections
;
drug therapy
;
Phytotherapy
;
Repressor Proteins
;
analysis
;
Uterine Cervical Neoplasms
;
drug therapy
;
virology
5.Diagnosis and management of hepatic angiomyolipoma
Yuxin ZHONG ; Wei PEI ; Liming WANG ; Fan WU ; Weiqi RONG ; Jianxiong WU ; Yongfu SHAO
Chinese Journal of General Surgery 2008;23(11):843-845
Objective To investigate the clinical characteristics, diagnosis, treatment and prognosis of hepatic angiomyolipoma (HAML). Methods The clinical data of 14 patients with hepatic angiomyolipoma admitted in our hospital from 1989 to 2007 were analyzed retrospectively. Result There were 4 male patients and 10 female patients. Median age was 41 years old. The lesions located in right lobe in 8 patients, and in left lobe in 6 patients. B-US was taken in 12 patients before operation, and other examinations included CT in 8 patients, MRI in 7 patients and angiography in 2 patients. Five patients were diagnosed with HAML by imagine features. Fine needle biopsy was taken in 1 patient with no definite diagnosis. All patients underwent resection and got the histopathologic diagnosis with HAML. All specimens were HMB-45 positive. S-100 and SMA were tested in 7 and 6 patients respectively, and were positive in all those patients. All cases were followed up for 6 months to 18 years (median time was 3 years). 13 patients were still alive without recurrence and 1 patient died of postoperative DIC and heart failure. Conclusion There was marked female predominance in HAML. Imaging features are helpful for preoperative diagnosis of HAML, but correct diagnosis was achieved in only a fraction of patients. HMB-45 positive was definitive proof for histopathologic diagnosis of HAML. Hepatectomy was an effective treatment for HAML.
7.Establishment and application of a high-throughput drug screening model based on COL1A1 promoter for anti-liver fibrosis.
Shuang-Shuang ZHAO ; Ju-Xian WANG ; Yu-Cheng WANG ; Rong-Guang SHAO ; Hong-Wei HE
Acta Pharmaceutica Sinica 2015;50(2):169-173
For screening the potential drugs as anti-liver fibrosis candidates, we established a high- throughput drug screening cell model based on COL1A1 promoter. The activity of COL1A1 promoter and luciferase reporter gene can be elevated by TGF-β1, and inhibited by candidate drugs. We constructed a recombined plasmid with COL1A1 promoter and luciferase reporter gene pGL4.17, the activity of COL1A1 promoter was reflected by fluorescence intensity. COL1A1 promoter activity was detected by Dual-Luciferase Reporter Assay System, it came that the relative luciferase activity of COL1A1 promoter was 15.98 times higher than that of control group induced by TGF-β1, showing the recombined plasmid could be used in cell model. The recombined plasmid was transfected into human hepatic stellate cells LX2, detected the effect of potential drugs, and obtained a stable expression system through stable transfection and monoclonal cell culture. A sample which could reduce COL1A1 promoter activity signally by our cell model, decreased collagen I mRNA and protein expression detected by real-time RT-PCR and Western blotting. It indicates this novel cell model can be used in high-throughput drug screening of potential anti-liver fibrosis drugs.
Collagen Type I
;
genetics
;
Drug Evaluation, Preclinical
;
methods
;
Genes, Reporter
;
Hepatic Stellate Cells
;
High-Throughput Screening Assays
;
Humans
;
Liver Cirrhosis
;
drug therapy
;
Luciferases
;
Plasmids
;
Promoter Regions, Genetic
;
RNA, Messenger
;
Transfection
;
Transforming Growth Factor beta1
;
pharmacology
8.A child with gastric stromal sarcoma.
Shao-ming ZHOU ; Lai-bao SUN ; Hong-ying LUO ; Ju-rong WEI ; Da-ming BAI
Chinese Journal of Pediatrics 2004;42(1):73-73
Child, Preschool
;
Female
;
Humans
;
Sarcoma
;
diagnosis
;
surgery
;
Stomach Neoplasms
;
diagnosis
;
surgery
;
Stromal Cells
;
pathology
9.Inhibitions of SphK1 inhibitor SKI II on cell cycle progression and cell invasion of hepatoma HepG2 cells.
Cai-Xia ZHANG ; Hong LIU ; Yu-Yan GONG ; Hong-Wei HE ; Rong-Guang SHAO
Acta Pharmaceutica Sinica 2014;49(2):204-208
Sphingosine kinase 1 (SphK1) plays critical roles in cell biological functions. Here we investigated the effects of SphK1 inhibitor SKI II on hepatoma HepG2 cell cycle progression and invasion. Cell survival was determined by SRB assay, cell cycle progression was assayed by flow cytometry, the ability of cell invasion was measured by Matrigel-Transwell assay and protein expression was detected by Western blotting. The results showed that SKI II markedly inhibited HepG2 cell survival in a dose-dependent manner, induced G1 phase arrest in HepG2 cell and inhibited cell invasion. SKI II markedly decreased the expressions of G1-phase-related proteins CDK2, CDK4 and Cdc2 and the levels of cell invasion-associated proteins MMP2 and MMP9. The results showed that SKI II inhibited cell cycle progression and cell invasion, implying SphK1 as a potential target for hepatoma treatment.
CDC2 Protein Kinase
;
Cell Movement
;
drug effects
;
Cell Survival
;
drug effects
;
Cyclin-Dependent Kinase 2
;
metabolism
;
Cyclin-Dependent Kinase 4
;
metabolism
;
Cyclin-Dependent Kinases
;
metabolism
;
G1 Phase
;
drug effects
;
Hep G2 Cells
;
Humans
;
Matrix Metalloproteinase 2
;
metabolism
;
Matrix Metalloproteinase 9
;
metabolism
;
Phosphotransferases (Alcohol Group Acceptor)
;
antagonists & inhibitors
;
Thiazoles
;
pharmacology
10.The synergistic effect of lidamycin and rituximab on human B cell lymphoma.
Yi-Ran SUN ; Sheng-Hua ZHANG ; Rong-Guang SHAO ; Hong-Wei HE
Acta Pharmaceutica Sinica 2014;49(2):198-203
This study aimed to investigate the synergistic effect of lidamycin (LDM) and rituximab on human B cell lymphoma Ramos cells. Cell proliferation was measured using MTS assay, cell apoptosis was analyzed by Annexin V-FITC/PI assay, the expression of apoptosis related proteins was analyzed by Western blotting, and the in vivo lymphoma inhibition was verified using BALB/c mice inoculated via tail vein using Ramos cells which stably expressed pEGFP-N1 plasmid. The results showed that, after the pretreatment with rituximab for 48 h, rituximab and LDM showed significantly synergistic effects on cell proliferation. Cells in combined treatment group had a higher apoptosis rate than that in LDM treatment group. Compared with the LDM treatment group, the expression of apoptosis-related proteins such as Cleaved caspase-3, Cleaved caspase-7, Cleaved caspase-9 and Cleaved PARP in combined treatment groups increased, and expression of cIAP-2 and Bcl-2 decreased. The result of in vivo experiment showed that, in the combined treatment group, the survival time of BALB/c mice was significantly longer than the mice in control group and LDM treatment group, and the degree of tumor accumulation and metastasis to lymph nodes and spleen was lower.
Aminoglycosides
;
pharmacology
;
Animals
;
Antibiotics, Antineoplastic
;
pharmacology
;
Antineoplastic Agents
;
pharmacology
;
Apoptosis
;
drug effects
;
Caspase 3
;
metabolism
;
Caspase 7
;
metabolism
;
Caspase 9
;
metabolism
;
Cell Line, Tumor
;
Cell Proliferation
;
drug effects
;
Drug Synergism
;
Enediynes
;
pharmacology
;
Humans
;
Inhibitor of Apoptosis Proteins
;
metabolism
;
Lymphoma, B-Cell
;
metabolism
;
pathology
;
Mice
;
Mice, Inbred BALB C
;
Mice, Nude
;
Neoplasm Metastasis
;
Neoplasm Transplantation
;
Poly(ADP-ribose) Polymerases
;
metabolism
;
Proto-Oncogene Proteins c-bcl-2
;
metabolism
;
Random Allocation
;
Rituximab
;
pharmacology